These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20439032)

  • 1. BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer.
    Zlotta AR; Cohen SM; Dinney C; Droller M; van der Kwast TH; van Rhijn BW; Bochner B; Ameil G; Jewett MA
    Urol Oncol; 2010; 28(3):329-33. PubMed ID: 20439032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progress.
    Robinson VL; Porter M; Messing E; Fradet Y; Kamat AM; Lotan Y
    Urol Oncol; 2010; 28(3):334-7. PubMed ID: 20439033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCAN Think Tank session 3: Prevention of bladder cancer.
    Lerner SP; Grossman HB; Messing EM; Kibel AS; Stephenson A; Gee JR; O'Donnell MA; Reid RD; Kamat AM; Parnes HL; House MG
    Urol Oncol; 2010; 28(3):338-42. PubMed ID: 20439034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the role of smoking in the aetiology of bladder cancer.
    Anderson B
    Br J Community Nurs; 2009 Sep; 14(9):385-92. PubMed ID: 19749657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder cancer: epidemiology, staging and grading, and diagnosis.
    Kirkali Z; Chan T; Manoharan M; Algaba F; Busch C; Cheng L; Kiemeney L; Kriegmair M; Montironi R; Murphy WM; Sesterhenn IA; Tachibana M; Weider J
    Urology; 2005 Dec; 66(6 Suppl 1):4-34. PubMed ID: 16399414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.
    Pietzak EJ; Mucksavage P; Guzzo TJ; Malkowicz SB
    Urology; 2015 Nov; 86(5):968-72. PubMed ID: 26190088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder cancer epidemiology and pathogenesis.
    Ross RK; Jones PA; Yu MC
    Semin Oncol; 1996 Oct; 23(5):536-45. PubMed ID: 8893866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs.
    Yuruk E; Tuken M; Colakerol A; Serefoglu EC
    Int Braz J Urol; 2017; 43(4):607-614. PubMed ID: 28537702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and etiology of bladder cancer.
    Cohen SM; Johansson SL
    Urol Clin North Am; 1992 Aug; 19(3):421-8. PubMed ID: 1636227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bladder cancer and occupational activity].
    Porru S; Scotto di Carlo A; Carta A; Placidi D
    G Ital Med Lav Ergon; 2003; 25(3):298-300. PubMed ID: 14582243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation.
    Strope SA; Montie JE
    J Urol; 2008 Jul; 180(1):31-7; discussion 37. PubMed ID: 18485400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder cancer and smoking. Part 1: addressing the associated risk factors.
    Anderson B; Naish W
    Br J Nurs; 2008 Oct 9-22; 17(18):1182-6. PubMed ID: 18946399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The causes of urinary bladder cancer and possibilities of prevention].
    Golka K; Rettenmeier AW; Goebell PJ
    Urologe A; 2006 Mar; 45(3):361-7; quiz 368. PubMed ID: 16514529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors in clonal development from superficial to invasive bladder cancer.
    Landman J; Droller MJ
    Cancer Surv; 1998; 31():5-15. PubMed ID: 15281314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL; Tannenbaum SR; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center.
    Guzzo TJ; Hockenberry MS; Mucksavage P; Bivalacqua TJ; Schoenberg MP
    Urology; 2012 Jan; 79(1):166-71. PubMed ID: 22030373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of bladder cancer.
    Malats N; Real FX
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):177-89, vii. PubMed ID: 25836927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Ishioka J; Saito K; Kijima T; Nakanishi Y; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Koga F; Masuda H; Fujii Y; Sakai Y; Arisawa C; Okuno T; Nagahama K; Kamata S; Sakura M; Yonese J; Morimoto S; Noro A; Tsujii T; Kitahara S; Gotoh S; Higashi Y; Kihara K
    BJU Int; 2015 May; 115(5):705-12. PubMed ID: 24612074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.